Glucagon’s ability to increase blood glucose concentrations seems to be influenced by the concentration of circulating insulin, and it is most effective in situations with impending hypoglycaemia and low systemic insulin concentrations (Castle et al., 2010; Bakhtiani et al., 2015). The gene discussed is GCG; the disease is Hypoglycemia.